Base Year
Historical Year
Forecast Year
The global digital therapeutics market size was valued at USD 4.5 billion in 2023, driven by the growing prevalence of telehealth services across the globe. The market is expected to grow at a CAGR of 31.6% during the forecast period of 2024-2032, with the values likely to rise from USD 5.92 billion in 2024 to USD 53.2 billion by 2032.
Digital therapeutics are therapeutic interventions that help in patient treatment, management, and disease prevention with the help of evidence based and clinically evaluated software. It delivers therapies using smartphones, tablets and similar technologies and offers clinically safe and effective therapies to patients. The market is impacted by the increasing prevalence of chronic diseases and the rising convergence of digital technologies, artificial intelligence, and machine learning capabilities along with the advent of sensor capabilities.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increased Application in Clinical Trials to Aid the Market Growth
In December 2023, ObvioHealth announced the launch of their new API (application programming interface), tailored particularly for digital therapeutic clinical trials. The new electronic clinical outcome assessment (eCOA) solution integrates enhanced study design technology with scientific and clinical services. It enables rapid publishing of the assessment on the mobile apps to offer more robust results for trial sponsors. It also evaluates patient engagement tactics and offers personalized assistance to patients, ensuring their safety as well.
Rising Collaborations Between Pharmaceutical Giants and Prescription Digital Therapeutics Makers
With the vision to integrate technology related components in their product range and enter the digital health space, several pharmaceutical companies have started partnering with PDTs. In September 2023, Bayer AG entered a partnership with Mahana Therapeutics to commercialize irritable bowel syndrome (IBS) related digital therapies. Mahana IBS, the company’s lead product uses cognitive behavioral therapy (CBT) to impact gut-brain communication. The agenda of such collaborations is primarily focused on connecting consumers with digital health tools. Hence, it is expected to impact the digital therapeutics market growth substantially.
Innovative Product Launches for Enhanced Services to Significantly Benefit the Market
To improve the quality of patient care in the upcoming ages, healthcare companies have realized that digital therapeutics is poised to play an active role in healthcare management. The shift has been significant, especially post COVID-19. Consequently, there have been comprehensive upgrades and new product launches to meet the rising digital therapeutics market demand. In November 2023, the Digital Therapeutics Alliance (DTA) launched a Policymaker & Payor DTx Evaluation Toolkit, which includes components like foundation setting materials, DTx assessment guides and implementation resources. It featured market access pathways, prescription vs non-prescription statuses, along with clinical and economic impact of products along with its security, privacy, usability, and evidence requirements.
Software Segment is Expected to Lead the Digital Therapeutics Market Share
Based on components, the market is broadly divided into software and devices. Out of the two, the software segment is projected to dominate the market, which can be attributed to rising prevalence of applications that improve the user interface and convenience for both patients and healthcare providers. There has been continuous development in the existing models to bring relevant changes. One such example is Freespira’s Bluetooth wireless technology enabled devices which come with sensor samples, measuring exhaled carbon dioxide and respiration rate, and directly transmitting the data to Freespira’s application.
Growing Emphasis on Preventive Healthcare in the Geriatric Population
The rising prevalence of chronic diseases, the need to reduce healthcare costs, a growing focus on preventive healthcare, and increasing investments in digital therapeutics are all driving the digital therapeutics market growth. Chronic diseases' high incidence rate is a serious problem for healthcare systems all over the world. Patients with chronic diseases provide a considerable barrier in terms of therapy, since psychosomatic or biopsychic variables frequently affect these patients. Many chronic diseases and conditions progress over time, and their prevalence rises as people get older. As a result, chronic diseases are expected to rise even more throughout the forecast period as the global geriatric population grows. This is expected to provide considerable growth opportunities for the digital therapeutics industry.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Application
Market Breakup by Component
Market Breakup by End-user
Market Breakup by Sales Channel
Market Breakup by Region
The United States, with a robust healthcare infrastructure that can integrate the digital advancements, is expected to dominate the digital therapeutics market size in the forecast period. The existence of impactful academic as well as research institutions drives the market growth in the region. The increasing adoption of telehealth services is another major aspect.
In March 2023, NeuroRPM received the FDA clearance for using artificial intelligence enabled remote monitoring app for Parkinson’s disease. It monitors the disease indications such as bradykinesia, tremor, and dyskinesia continuously using proprietary algorithms. This indicates the ongoing trend of healthcare practitioners and companies adopting digital services to improve the treatment alternatives for patients. Similar have been employed for migraine, PTSD, psychiatric conditions, and chronic lung diseases like CAD as well.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
In October 2023, Sidekick Health acquired aidhere, a Germany based pioneer of prescription digital therapeutics. This acquisition also loops in zanadio, which is one of the most successful PDTs with over 50,000 prescriptions and is recognised within Germany’s self-regulated DiGA. It strengthens Sidekick Health’s portfolio as a trusted partner for pharmaceutical giants and global health insurers.
The market has been flourished with relevant developments, wherein several companies have been undergoing significant transformations to expand their product portfolio. The key features of the digital therapeutics market report include grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Applications |
|
| Breakup by Component |
|
| Breakup by End User |
|
| Breakup by Sales Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Digital Therapeutics Market Size
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 4.5 billion in 2023, driven by the prevalence of telehealth services across the globe.
The market is anticipated to grow at a CAGR of 31.6% during the forecast period of 2024-2032, likely to reach a market value of USD 53.2 billion by 2032.
The market demand is driven by the increasing prevalence of chronic diseases, growing geriatric population, and rising convergence of digital health and related services in the healthcare ecosystem.
The major market trend revolves around increasing mergers and collaborations between influential healthcare companies, aimed at expanding their product lines and offer digital health services to the patients. In September 2023, Bayer AG entered a collaboration with Mahana Therapeutics to commercialize irritable bowel syndrome (IBS) related digital therapies.
Software and devices are common components available in the market.
Common application areas include preventive care and treatment. Preventive is further segmented into prediabetes, obesity, and others. Treatment divides into diabetes, respiratory care, mental health, cardiovascular and others.
Based on sales channels, the market is divided into B2B and B2C.
Major end users include patients, providers, payers, employers, and others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are Omada Health, Inc, Welldoc, Inc., 2Morrow, Inc., Livongo Health, Inc. (Teladoc Health, Inc.), Propeller Health (ResMed), Fitbit LLC, Mango Health, Canary Health, Noom, Inc., Pear Therapeutics, Inc., Akill Interactive Labs, Inc., JOGO Health, GAIA AG, CureApp, Inc. and Brain+ A/S.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share